Svenningsson, A Frisell, T Burman, J Salzer, J Fink, K Hallberg, S Hambraeus, J Axelsson, M Al Nimer, F Sundstrom, P Piehl, F Lycke, J, 2022, Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial, The Lancet. Mohanta, SK Peng, L Li, YF Lu, S Sun, T Carnevale, L Perrotta, M Ma, Z Forstera, B Stanic, K Carnevale, D Habenicht, AJR, 2022, Neuroimmune cardiovascular interfaces control atherosclerosis, Nature, 7908, 605, 10.1038/s41583-6. Magnus, MC Ortqvist, AK Dahlqwist, E Ljung, R Skar, F Oakley, L Macsali, F Pasternak, B Gjessing, HK Haberg, SE Stephansson, O, 2022, Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes, JAMA, 15, 327, 10.1001/jama.2022.3271.Įdlund, C Ternhag, A Stahlgren, GS Edquist, P Balkhed, AO Athlin, S Mansson, E Tempe, M Bergstrom, J Giske, CG Hanberger, H Temociffin Study Grp, 2022, The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden, The Lancet. Reich, K Thyssen, JP Blauvelt, A Eyerich, K Soong, W Rice, ZP Hong, HCH Katoh, N Valenzuela, F DiBonaventura, M Valdez, H Kerkmann, U, 2022, Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial, Lancet, 10348, 400, 10.1016/S0140-6736(22)01199-0. Originalartiklar som under 2022 har publicerats av forskare på MedS och som har en Journal Impact Factor på 25 eller högre:Įdqvist, M Dahlen, HG Haggsgard, C Tern, H Angeby, K Teleman, P Ajne, G Rubertsson, C, 2022, The effect of two midwives during the second stage of labour to reduce severe perineal trauma (Oneplus): a multicentre, randomised controlled trial in Sweden. Längst ned finns också ett dokument med samtliga artiklar publicerade de senaste tre åren och som har citerats 50 gånger eller fler. På den här sidan listas de originalpublikationer från 2022 som har en Journal Impact Factor på 25 eller mer, samt de originalpublikationer som under åren 2020 till 2022 har citerats mer än 100 gånger.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |